Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs ProShares UltraPro QQQ ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.59 (market cap $2.27B), while ProShares UltraPro QQQ ETF trades at $81.12 (market cap $38.74B). The key difference: ProShares UltraPro QQQ ETF is far larger — about 17.1× SELLAS Life Sciences Group Inc. Common Stock's market cap, and ProShares UltraPro QQQ ETF is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | TQQQ | |
|---|---|---|
Market Cap | $2.27B | $38.74B |
Volume | 4,179,659 | 65,384,797 |
Sector | Health | Leveraged / Inverse |
52-Week High | $15.46 | $87.22 |
52-Week Low | $1.39 | $37.89 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TQQQ trades at $80.67, down 3.5% in the last session amid mixed technical signals. The ETF maintains a bullish overall technical rating with strong moving average support but faces neutral oscillators. Recent news highlights significant hidden costs beyond the stated 0.82% expense ratio, including financing charges that impact returns. Institutional activity shows mixed positioning with some firms reducing stakes while others add exposure.
Outlook remains volatile given TQQQ's 3x leveraged structure, which amplifies both gains and losses. The ETF faces headwinds from volatility decay and hidden costs, though AI-driven tech growth provides underlying support. Key risks include amplified drawdowns during market corrections and structural costs that erode long-term performance versus the underlying index.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
